Coenzyme Q10 / Risk Cancer Research Results

CoQ10, Coenzyme Q10: Click to Expand ⟱

Features:

Coenzyme Q10 (CoQ10), also known as ubiquinone, is a fat-soluble antioxidant and a critical component of the mitochondrial electron transport chain, essential for ATP production. Its potential role in Alzheimer’s disease (AD) and cancer has been increasingly studied, mainly due to its effects on oxidative stress, mitochondrial function, and cellular energy metabolism.

Two types: ubiquinone(standard) vs ubiquinol(more bioavailable)

-high content in beef heart -Acts as an antioxidant, reducing ROS
-Some preclinical studies suggest CoQ10 may reduce Aβ-induced neurotoxicity
-CoQ10 is sometimes used with chemotherapy to reduce cardiotoxicity (especially with doxorubicin).
-Essential for ATP (energy) production.

-CoQ10 levels may drop by 25–40% in people taking statins.
-May support mitochondrial function in neurodegenerative diseases, including Alzheimer’s and Parkinson’s

Coenzyme Q10 exists in three redox states:
Form	         Name	          Abbreviation	Redox state
Oxidized	Ubiquinone	    CoQ10	Oxidized (labeled “Coenzyme Q10”, “CoQ10”)
Semiquinone	Ubiquinol radical   CoQ10•–	Intermediate (labeled “Ubiquinol”, “Reduced CoQ10”)
Reduced	        Ubiquinol	    CoQ10H₂	Reduced

Most supplements = ubiquinol (reduced, antioxidant)
  Ubiquinol is often preferred for cardiovascular, aging, and antioxidant-focused use.
BPM31510 = ubiquinone (oxidized) (might raise ROS in cancer cells)

>80–95% of circulating CoQ10 is ubiquinol, regardless of whether ubiquinone or ubiquinol was ingested

-CoQ10 is fat-soluble, so take it alongside meals that include nutrient-dense fats like coconut oil, butter or tallow in moderation
-initial 200-300mg/day (split during day) down to 100mg after 21 days

BPM31510: Pharmaceutical oxidized CoQ10
BPM31510 = oxidized CoQ10 (ubiquinone) in a specialized lipid formulation.
BPM31510 increases Mitochondrial ROS in cancer cells. That increase is intentional, central to its mechanism, and relatively selective for tumor cells.
BPM31510 Studies report in cancer cells:
↑ mitochondrial ROS
↑ lipid peroxidation
↓ NADPH/NADP⁺ ratio
↓ GSH/GSSG ratio
Activation of oxidative stress pathways
Cell death without classic antioxidant rescue
Importantly: Trolox, NAC, or GSH can partially blunt BPM31510 effects, confirming ROS dependence

Coenzyme Q10 (CoQ10 / Ubiquinone) — Cancer vs Normal Cell Effects

Rank	Pathway / Axis	Cancer Cells	Normal Cells	Label	Primary Interpretation	Notes
1	Mitochondrial electron transport (ETC)	↔ or ↓ metabolic advantage	↑ ETC efficiency	Driver	Mitochondrial bioenergetic support	CoQ10 improves electron transport and ATP efficiency primarily in normal cells
2	Reactive oxygen species (ROS)	↓ ROS (antioxidant)	↓ ROS (strong buffering)	Driver	Antioxidant dominance	CoQ10 limits lipid peroxidation and mitochondrial ROS production
3	Mitochondrial membrane stability	↔ stabilized (may reduce stress signaling)	↑ membrane protection	Secondary	Mitochondrial resilience	Stabilization favors normal cells and may blunt oxidative stress-based cancer therapies
4	Inflammatory signaling (NF-κB / cytokines)	↓ inflammatory microenvironment	↓ inflammation	Secondary	Anti-inflammatory milieu	Reduced inflammation may limit tumor promotion but is not directly cytotoxic
5	Cell proliferation	↔ or mildly ↓	↔	Phenotypic	Growth neutrality	CoQ10 does not strongly inhibit proliferation in most cancer models
6	Apoptosis	↓ apoptosis (stress protection)	↓ apoptosis	Phenotypic	Cytoprotection	Anti-apoptotic effect reflects antioxidant and mitochondrial protection

Risk, Risk: Click to Expand ⟱

Source:

Type:

Risk: by definition reduces risk of disease or cancer.
Down Target direction of risk indicates lower cancer risk.
ChemoPreventive also mean lower cancer risk. But for Chemopreventive an up arrow indicates more preventive.

Cancer Risk Impact Score (CRIS)
CRIS scale:
–5 = very strong risk reduction
–4 = strong risk reduction
–3 = moderate risk reduction
–2 = modest risk reduction
–1 = weak / context-dependent
0 = neutral


CRIS  Exposure / Compound  Evidence  Cancers  Notes


-5  Exercise (overall)
VStrong Hum  BC, CRC, Endo, PCa, Liv
↓insulin/IGF-1, ↓inflammation, ↑immune surveillance, ↓hormones



-5  Aerobic + resistance  VStrong Hum  Broad inc + mort
Best overall exercise synergy



-4  Aerobic exercise (mod–vig)  VStrong Hum  BC, CRC, Endo
Dose–response; ↓visceral fat



-4  Resistance training (alone)  Strong Hum  BC, CRC
↑insulin sensitivity; ↑lean mass



-3  High-intensity interval training  Mod–Strong Hum  BC, CRC
↑AMPK; ↑mitochondrial function; adherence matters



-2  NEAT / low-intensity activity  Moderate Hum  CRC
↓sedentary harm



-5  Cruciferous vegetable pattern  Strong Hum  Lung, CRC, BC, PCa
↑NRF2, ↓CYP1; ITC synergy



-5  Sunlight exposure (physiologic)  Strong Hum  CRC, BC, PCa
↑circadian alignment, ↑immune effects beyond vitamin D



-4  Fasting (metabolic pattern)
Strong Mech + Hum  BC, CRC, PCa 
↓IGF-1, ↓mTOR, ↑autophagy



-4  Curcumin
Hum + Pre  GI, BC, PCa
↓NF-κB, ↓STAT3



-4  Sulforaphane
Hum + Pre  Lung, CRC, BC
↑NRF2, ↓HDAC



-4  PEITC
Hum + Pre  Lung, CRC, PCa
↓CYP1A2, ↑apoptosis



-4  EGCG (tea matrix)
Strong Hum  GI, PCa, BC
↓angiogenesis; tea matrix superior to extract



-4  Lycopene
Strong Hum  PCa
↓oxidative DNA damage



-4  Apigenin
Pre + Diet Hum  BC, PCa, CRC 
↓PI3K-AKT, ↑p53



-4  Luteolin
Pre + Diet Hum  Lung, CRC, BC 
↓STAT3, ↓EMT



-4  Kaempferol
Diet Hum  Ov, Panc, Lung
↓VEGF, ↑apoptosis



-4  Fisetin
Pre + Early Hum  CRC, PCa, Mel
↓mTOR; senolytic activity



-4  Ellagic acid → Urolithin A
Hum (microbiome)  CRC, PCa, BC
↑mitophagy, ↓ER/AR signaling



-3  Omega-3 (EPA/DHA)
Strong Hum  CRC, BC
↓inflammation, ↓COX-2



-3  Vitamin D3 (supp)
Obs + RCT  CRC, BC
U-shaped response; ↓proliferation



-3  Garlic (allicin)
Mod Hum  GI
↓inflammation, ↓H. pylori



-3  Mushroom beta-glucans
Hum adjunct  GI, BC
↑NK cells, ↑immune surveillance



-3  Melatonin
Hum + Mech  BC, PCa
↓estrogen signaling, ↑circadian regulation



-3  Coffee (whole)
Strong Hum  Liv, Endo
↓fibrosis, ↓inflammation



-2  Quercetin
Limited Hum  Lung, CRC
Senolytic; ↓PI3K signaling



-2  Resveratrol
Limited Hum  CRC, BC
↓NF-κB; low bioavailability



-2  I3C / DIM
Mod Hum  BC, Cerv
↑2-OH estrogen, ↓ER signaling



-2  Thymoquinone
Early Hum  BC, CRC
↑apoptosis, ↓NF-κB



-2  Beta-carotene (food)
Hum  Lung
Antioxidant only in whole-food context



-1  Vitamin K2 (MK-4/7)
Limited Hum  Liv, PCa
↓proliferation, ↑differentiation



-1  Boron
Obs  PCa, Lung
↓inflammation; hormone modulation



0  Vitamin C (oral)
Strong Hum  —
Neutral overall effect



0  Genistein (soy)
Strong Hum  BC, PCa
Timing-dependent effects



0  Selenium (diet)
Mixed Hum  PCa
Narrow therapeutic window



0  Capsaicin
Mixed  Gastric
Dose-dependent effects



+2  Vitamin E (alpha only)
Strong RCT  PCa
Increased risk signal



+2  Green tea extract (high-dose)
Case reports  Liv
Hepatotoxicity reported



+4  Beta-carotene (supplement)
Strong RCT  Lung (smokers)
Increased lung cancer risk in smokers



+5  Alcohol (ethanol)
Strong Hum  BC, Liv, Eso
Linear increase in cancer risk




Evidence
Hum        human data
VStrong    very strong
Strong     strong
Mod        moderate
Obs        observational
Pre        preclinical
RCT        randomized controlled trial
Mech       mechanistic
Adjunct    adjunct clinical use

Scientific Papers found: Click to Expand⟱

4770-

CoQ10,

VitK2,

Cancer cell stiffening via CoQ10 and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer

in-vitro,

BC,

MDA-MB-231

other↑, *antiOx↑, Risk↓, other↑, TumMeta↓, ECM/TCF↓, Akt2↓, Ferroptosis↑, eff↑,

4769-

CoQ10,

CoQ10 Is Key for Cellular Energy and Cancer Support

Review,

Var,

Risk↓, TumCG↓, angioG↓, TumCD↑, *toxicity↓, *BioAv↑, MMPs↓, Inflam↓, chemoP↑, cardioP↑, *ROS↓, *toxicity↝, Dose?,

4768-

CoQ10,

Role of coenzymes in cancer metabolism

Review,

Var,

Risk↓, *ROS↓, AntiCan↑, TumMeta↓, ROS↑, TumCG↓, Apoptosis↑, TumMeta↓, Wnt↓, β-catenin/ZEB1↓, TumCG↓, selectivity↑, RadioS↑, ChemoSen↑, H2O2↓, MMP2↓, cardioP↑, ChemoSen∅, Dose↝,

4766-

CoQ10,

Activities of Vitamin Q10in Animal Models and a Serious Deficiency in Patients with Cancer

Review,

Var,

Risk↓,

Showing Research Papers: 1 to 4 of 4

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4

Pathway results for Effect on Cancer / Diseased Cells:

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

antiOx↑, 1, ROS↓, 2,

Drug Metabolism & Resistance ⓘ

BioAv↑, 1,

Functional Outcomes ⓘ

toxicity↓, 1, toxicity↝, 1,
Total Targets: 5

Scientific Paper Hit Count for: Risk, Risk

4 Coenzyme Q10
1 Vitamin K2

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:356  Target#:785  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

Coenzyme Q10 / Risk Cancer Research Results

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

Cell Death ⓘ

Transcription & Epigenetics ⓘ

Proliferation, Differentiation & Cell State ⓘ

Migration ⓘ

Angiogenesis & Vasculature ⓘ

Immune & Inflammatory Signaling ⓘ

Drug Metabolism & Resistance ⓘ

Functional Outcomes ⓘ

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

Drug Metabolism & Resistance ⓘ

Functional Outcomes ⓘ

Home Page